Search results
ADDF invests $5 million in Coya Therapeutics for FTD treatment By Investing.com
Investing.com· 15 hours agoCoya Therapeutics, Inc. (NASDAQ:COYA), a biotech firm focusing on regulatory T cell therapies, has...
Lexaria (NASDAQ: LEXX) Announces Commencement of Dosing in GLP-1 Animal Study
Digital Journal· 16 hours agoWith broad reach and a seasoned team of contributing journalists and writers, CBDW is uniquely positioned to best serve private and public companies that want to reach a wide audience...
North Wilkesboro Speedway is fully back. Will Rockingham’s track also return to NASCAR?
Hilton Head Island Packet via AOL· 23 hours agoThe money has come from two different avenues. The first is from the government. In November 2021,...
Who is Iran’s first vice president, Mohammad Mokhber, appointed acting president after crash?
The Washington Times· 22 hours agoIran‘s first Vice President Mohammad Mokhber was appointed as acting president of the Islamic...
MDs Reveal the Top 2 Stomach Ulcer Causes (Stress Isn't One of Them) + How to Block a Flare-Up
Woman's World via Yahoo News· 21 hours agoUradomo. They affect upwards of 6% of the population, which translates to some 20 million people....
Plus Therapeutics Inc (PSTV) Q1 2024 Earnings Call Transcript Highlights: Strategic Progress ...
GuruFocus.com via Yahoo Finance· 5 days agoThe company is still in the early stages of discussion with the FDA regarding the multi-dose expansion arm for their Phase 1 trial, indicating potential delays in trial progression ...
Who are the ‘Liberty’ Republicans in Kentucky politics? What do they want?
Lexington Herald-Leader via Yahoo News· 22 hours agoAndy Beshear’s vetoes. The money has followed the consequence of this political battle. All told,...
Who is Iran’s first vice president, Mohammad Mokhber, appointed acting president after crash?
WSYR 9 Syracuse· 22 hours agoDUBAI, United Arab Emirates (AP) — Iran’s first Vice President Mohammad Mokhber was appointed as...
Hims & Hers says it's selling a GLP-1 weight loss drug for 85% less than Wegovy. Here's the price.
CBS News· 14 hours agoDirect-to-consumer pharmaceutical startup Hims & Hers Health said it is selling injectable GLP-1...
BioAtla Inc (BCAB) (Q1 2024) Earnings Call Transcript Highlights: Strategic Adjustments and ...
GuruFocus.com via Yahoo Finance· 6 days agoExpected Operating Cash Burn: Approximately $20 million for Q2 2024, with a decrease anticipated in the second half of the year. Funding Operations: Current...and an 86% disease ...